severe oral mucositis

Related by string. * se vere . SEVERE . Severe : Severe Acute Respiratory Syndrome . severe abdominal pain . severe acute respiratory . severe thunderstorm warnings / ORAL . orals . Oral : TULSA Okla. Oral Roberts . hear oral arguments . hears oral arguments / Mucositis : pyrexia mucositis sepsis febrile . mucositis radiation dermatitis . mucositis stomatitis vomiting dyspepsia * *

Related by context. Frequent words. (Click for all words.) 68 tumor lysis syndrome 68 Initiate Phase 67 Chronic Hepatitis C 67 Idiopathic Pulmonary Fibrosis 67 nephrotoxicity 67 post herpetic neuralgia PHN 67 refractory chronic lymphocytic 67 Metastatic Colorectal Cancer 66 febrile neutropenia 66 acute GVHD 66 Pivotal Phase 66 relapsing multiple sclerosis 66 leukemia ALL 66 Denufosol 66 chemotherapy induced neutropenia 66 Epratuzumab 66 forodesine 66 II Clinical Trial 65 venous thromboembolic events 65 Pivotal Phase III 65 Metastatic Melanoma 65 corticosteroid therapy 65 postherpetic neuralgia PHN 65 oral mucositis 65 Proxinium TM 65 TORISEL 64 Phase III Clinical Trial 64 gout flares 64 Initiates Phase 64 Acute Myeloid Leukemia AML 64 chemoradiotherapy 64 pheochromocytoma 64 Neutropenia 64 Single Dose 64 hypercalcemia 64 hematologic toxicity 64 Natalizumab 64 plus gemcitabine 64 Monotherapy 64 Panzem R 64 Adalimumab 63 Community Acquired Pneumonia 63 Dasatinib 63 Ischemic 63 Irinotecan 63 receiving VELCADE 63 trimethoprim sulfamethoxazole 63 Torisel 63 Phase III Trial 63 Thrombocytopenia 63 multiple myeloma MM 63 Chronic Lymphocytic Leukemia 63 gastrointestinal stromal tumors GIST 63 advanced carcinoid 63 mycophenolate mofetil 63 colorectal carcinoma 63 Recombinant Human 63 hypersensitivity reaction 63 cholangiocarcinoma 63 Pivotal Trial 63 Phase Ib clinical 63 superficial bladder cancer 63 secondary hyperparathyroidism 63 Pulmonary Arterial Hypertension 63 hypomagnesemia 63 mRCC 63 Chronic Heart Failure 63 immune modulator 62 Completes Enrollment 62 heparin induced thrombocytopenia 62 Presents Positive 62 Carcinoma 62 Ofatumumab 62 voriconazole 62 lymphoma CTCL 62 CMV disease 62 Clinical Trial Results 62 Patients Treated 62 murine model 62 phase IIb clinical 62 mucositis 62 multicenter Phase 62 sensory neuropathy 62 leukemia CLL 62 painful diabetic neuropathy 62 SHPT 62 thromboembolic events 62 pancreatic insufficiency 62 patients undergoing percutaneous 62 juvenile idiopathic arthritis 62 TYGACIL 62 lupus nephritis 62 Intranasal 62 Traficet EN 62 acute myelogenous leukemia AML 62 IV melanoma 62 Secondary endpoints include 62 Vandetanib 62 chronic HCV infection 62 Heart Failure Patients 62 CMV infection

Back to home page